awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q27021870-FAF0231C-CFC9-4E1D-844D-A2A83AD349F4
Q27021870-FAF0231C-CFC9-4E1D-844D-A2A83AD349F4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27021870-FAF0231C-CFC9-4E1D-844D-A2A83AD349F4
Treatment of type 2 diabetes, lifestyle, GLP1 agonists and DPP4 inhibitors
P2860
Q27021870-FAF0231C-CFC9-4E1D-844D-A2A83AD349F4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27021870-FAF0231C-CFC9-4E1D-844D-A2A83AD349F4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b9f03e1effe26c1063afdff630d3ffe8a4d4453b
P2860
Dipeptidyl peptidase-4 inhibitor, sitagliptin, improves endothelial dysfunction in association with its anti-inflammatory effects in patients with coronary artery disease and uncontrolled diabetes.